DALLAS: Researchers have shown that reducing inflammation in the brain could potentially protect against memory and behavioural changes linked with the progression of Alzheimer’s disease, raising hopes of a new treatment pathway for the condition.
The study, led by researchers at Southampton University, showed that blocking a receptor in the brain responsible for regulating immune cells could limit the damaging effects of inflammation and protect against some of the symptoms of the disease.
Researchers found that mice given a drug that blocks the action of the CSF1R protein, which regulates a particular type of immune cell, showed an improvement in symptoms compared to those who hadn’t received treatment, adding weight to the notion that inflammation in the brain could drive development of the disease…